Skip to main content
Top
Published in: Trials 1/2019

Open Access 01-12-2019 | Commentary

Trial management: we need a cadre of high-class triallists to deliver the answers that patients need

Authors: Danielle Beaumont, Monica Arribas, Lauren Frimley, Eni Balogun, Ian Roberts, Haleema Shakur-Still

Published in: Trials | Issue 1/2019

Login to get access

Abstract

Expert trial managers with the training and experience to overcome operational challenges are often the difference between the success and failure of a clinical trial. Considerable importance is given to the beginning and the end of the clinical trial process, with those responsible for writing a protocol, obtaining funding and analysing the data all being rewarded when the results are published. Yet, trial managers are often overlooked in terms of recognition, value and status. This article highlights some of the key barriers to achieving this and makes suggestions on how they can be addressed within clinical trials units registered with the UK Clinical Research Collaboration.
Literature
6.
go back to reference WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105–16.CrossRef WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105–16.CrossRef
7.
go back to reference Roberts I. Women’s work in UK clinical trials is undervalued. Lancet. 2018;392:732.CrossRef Roberts I. Women’s work in UK clinical trials is undervalued. Lancet. 2018;392:732.CrossRef
8.
go back to reference CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo controlled trial. Lancet. 2004;364:1321–8.CrossRef CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo controlled trial. Lancet. 2004;364:1321–8.CrossRef
9.
go back to reference CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.CrossRef CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.CrossRef
10.
go back to reference Dewan Y, Komolafe EO, Mejía-Mantilla JH, Perel P, Roberts I, Shakur H. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012;13:87.CrossRef Dewan Y, Komolafe EO, Mejía-Mantilla JH, Perel P, Roberts I, Shakur H. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012;13:87.CrossRef
11.
go back to reference Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K, et al. HALT-IT—tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Trials. 2014;15:450.CrossRef Roberts I, Coats T, Edwards P, Gilmore I, Jairath V, Ker K, et al. HALT-IT—tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Trials. 2014;15:450.CrossRef
13.
go back to reference Farrell B. Efficient management of randomised controlled trials: nature or nurture. BMJ. 1998;317:1236–9.CrossRef Farrell B. Efficient management of randomised controlled trials: nature or nurture. BMJ. 1998;317:1236–9.CrossRef
14.
go back to reference Farrell B, Kenyon S, Shakur H. Managing clinical trials. Trials. 2010;11:78.CrossRef Farrell B, Kenyon S, Shakur H. Managing clinical trials. Trials. 2010;11:78.CrossRef
15.
go back to reference Treweek S, Bevan S, Bower P, et al. Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)? Trials. 2018;19(1):139.CrossRef Treweek S, Bevan S, Bower P, et al. Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)? Trials. 2018;19(1):139.CrossRef
16.
go back to reference Rick J, Clarke M, Montgomery A, et al. Doing trials within trials: a qualitative study of stakeholder views on barriers and facilitators to the routine adoption of methodology research in clinical trials. Trials. 2018;19:481.CrossRef Rick J, Clarke M, Montgomery A, et al. Doing trials within trials: a qualitative study of stakeholder views on barriers and facilitators to the routine adoption of methodology research in clinical trials. Trials. 2018;19:481.CrossRef
17.
go back to reference Peckham E, Arundel C, Bailey D, et al. and on behalf of the SCIMITAR+ collaborative. Successful recruitment to trials: findings from the SCIMITAR+ Trial. Trials. 2018;19:53.CrossRef Peckham E, Arundel C, Bailey D, et al. and on behalf of the SCIMITAR+ collaborative. Successful recruitment to trials: findings from the SCIMITAR+ Trial. Trials. 2018;19:53.CrossRef
18.
go back to reference Bonsu JM, Frasso R, Curry AE. Lessons from the field: the conduct of randomized controlled trials in Botswana. Trials. 2017;18:503.CrossRef Bonsu JM, Frasso R, Curry AE. Lessons from the field: the conduct of randomized controlled trials in Botswana. Trials. 2017;18:503.CrossRef
19.
go back to reference Kaur G, Smyth RL, Powell CVE, Williamson P. A survey of facilitators and barriers to recruitment to the MAGNETIC trial. Trials. 2016;17:607.CrossRef Kaur G, Smyth RL, Powell CVE, Williamson P. A survey of facilitators and barriers to recruitment to the MAGNETIC trial. Trials. 2016;17:607.CrossRef
20.
go back to reference European Commission. More women in senior positions – key to economic stability and growth. 2010. European Commission. More women in senior positions – key to economic stability and growth. 2010.
21.
go back to reference Caffrey L, Wyatt D, Fudge N, et al. Gender equity programmes in academic medicine: a realist evaluation approach to Athena SWAN processes. BMJ Open. 2016;6:e012090.CrossRef Caffrey L, Wyatt D, Fudge N, et al. Gender equity programmes in academic medicine: a realist evaluation approach to Athena SWAN processes. BMJ Open. 2016;6:e012090.CrossRef
22.
go back to reference Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R. Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997–2010. BMJ Open. 2013;3:e003362.CrossRef Head MG, Fitchett JR, Cooke MK, Wurie FB, Atun R. Differences in research funding for women scientists: a systematic comparison of UK investments in global infectious disease research during 1997–2010. BMJ Open. 2013;3:e003362.CrossRef
23.
go back to reference Zhou CD, Head MG, Marshall DC, et al. A systematic analysis of UK cancer research funding by gender of primary investigator. BMJ Open. 2018;8:e018625.CrossRef Zhou CD, Head MG, Marshall DC, et al. A systematic analysis of UK cancer research funding by gender of primary investigator. BMJ Open. 2018;8:e018625.CrossRef
24.
go back to reference Warlow CP. How to do it: Organise a multicentre trial. BMJ. 1990;300:180–3.CrossRef Warlow CP. How to do it: Organise a multicentre trial. BMJ. 1990;300:180–3.CrossRef
25.
go back to reference Morgan R, Dhatt R, Muraya K, Buse K, George AS. Recognition matters: only one in ten awards given to women. Lancet. 2017;389:10088. Morgan R, Dhatt R, Muraya K, Buse K, George AS. Recognition matters: only one in ten awards given to women. Lancet. 2017;389:10088.
26.
go back to reference Ford HL, Brick C, Blaufuss K, Dekens PS. Gender inequity in speaking opportunities at the American Geophysical Union Fall Meeting. Nat Commun. 2018;9:1358.CrossRef Ford HL, Brick C, Blaufuss K, Dekens PS. Gender inequity in speaking opportunities at the American Geophysical Union Fall Meeting. Nat Commun. 2018;9:1358.CrossRef
27.
go back to reference Lundine J, Bourgeault IL, Clark J, Shirin Heidari S, Balabanova D. The gendered system of academic publishing. Lancet. 2018;391:10132.CrossRef Lundine J, Bourgeault IL, Clark J, Shirin Heidari S, Balabanova D. The gendered system of academic publishing. Lancet. 2018;391:10132.CrossRef
29.
go back to reference Haynes MC, Heilman ME. It Had to Be You (Not Me)!: Women’s Attributional Rationalization of Their Contribution to Successful Joint Work Outcomes. Personal Soc Psychol Bull. 2013;39(7):956–69.CrossRef Haynes MC, Heilman ME. It Had to Be You (Not Me)!: Women’s Attributional Rationalization of Their Contribution to Successful Joint Work Outcomes. Personal Soc Psychol Bull. 2013;39(7):956–69.CrossRef
30.
go back to reference Mccallin A. Interdisciplinary practice – a matter of teamwork: an integrated literature review. J Clin Nurs. 2001;10:419–28.CrossRef Mccallin A. Interdisciplinary practice – a matter of teamwork: an integrated literature review. J Clin Nurs. 2001;10:419–28.CrossRef
31.
go back to reference Nixon J, Cotterill L, Cooper M, Meadows H. NIHR Trial Managers’ Network, NIHR Trainees Coordinating Centre and the NCRI Accredited CTU Training Sub-Group Joint Project. Task, Knowledge and Competency Framework for Trial Managers; 2012. Nixon J, Cotterill L, Cooper M, Meadows H. NIHR Trial Managers’ Network, NIHR Trainees Coordinating Centre and the NCRI Accredited CTU Training Sub-Group Joint Project. Task, Knowledge and Competency Framework for Trial Managers; 2012.
Metadata
Title
Trial management: we need a cadre of high-class triallists to deliver the answers that patients need
Authors
Danielle Beaumont
Monica Arribas
Lauren Frimley
Eni Balogun
Ian Roberts
Haleema Shakur-Still
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Trials / Issue 1/2019
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3451-z

Other articles of this Issue 1/2019

Trials 1/2019 Go to the issue